All Pharma News
NMD Pharma Receives FDA IND Clearance to initiate a Ph2b Trial of NMD670

NMD Pharma Receives FDA IND Clearance to initiate a Ph2b Trial of NMD670
GLOBENEWSWIRE
22 Mar 2024
Share Share
NMD Publishes Comprehensive Data Package for NMD670 in Science

NMD Publishes Comprehensive Data Package for NMD670 in Science
GLOBENEWSWIRE
21 Mar 2024
Share Share
NMD Pharma announces presentations on skeletal muscle targeted ClC-1 therapy

NMD Pharma announces presentations on skeletal muscle targeted ClC-1 therapy
GLOBENEWSWIRE
01 Mar 2024
Share Share
NMD Pharma Appoints Morten Bull as SVP

NMD Pharma Appoints Morten Bull as SVP
GLOBENEWSWIRE
22 Jan 2024
Share Share
NMD Pharma Raises ‚¬75 Million (~$80 million) in a Series B Financing

NMD Pharma Raises ‚¬75 Million (~$80 million) in a Series B Financing
GLOBENEWSWIRE
15 Nov 2023
Share Share
NMD Pharma to present NMD670 clinical data from a Phase I/IIa trial

NMD Pharma to present NMD670 clinical data from a Phase I/IIa trial
GLOBENEWSWIRE
03 Oct 2023
Share Share
NMD Pharma to present NMD670 clinical data from a Phase I/IIa trial

NMD Pharma to present NMD670 clinical data from a Phase I/IIa trial
GLOBENEWSWIRE
02 Oct 2023
Share Share
NMD Pharma initiates Phase II trial of NMD670 in Spinal Muscular Atrophy

NMD Pharma initiates Phase II trial of NMD670 in Spinal Muscular Atrophy
GLOBENEWSWIRE
26 Sep 2023
Share Share
NMD Pharma to host a Satellite Symposium

NMD Pharma to host a Satellite Symposium
GLOBENEWSWIRE
08 Sep 2023
Share Share
NMD Reports Results from ESTABLISH Study “ an International Observational Study

NMD Reports Results from ESTABLISH Study “ an International Observational Study
GLOBENEWSWIRE
20 Jun 2023
Share Share